Radiometer logo

Transcutaneous CO2 Monitoring in Clinical Practice

April 9, 2020

This webinar is presented by Dr Milind Sovani, Honorary Assistant Professor and Consultant Respiratory Physician at Queen's Medical Centre, Nottingham University Hospital

Recording

About this webinar

This webinar will look at the technique and uses of Transcutaneous CO2 Monitoring in both ventilation and sleep.

About the speaker

Dr Milind Sovani is Honorary Assistant Professor and Consultant Respiratory Physician at Queen's Medical Centre, Nottingham University Hospital.

He completed his Batchelor of Medicine, Batchelor of Surgery degree (MBBS) at the Nagpur University, India and went onto gain his postgraduate Medical Diploma in the UK (MRCP(UK) in 2000. This was followed by a Doctorate of Medicine at the University of Nottingham in 2007 and a European Diploma in Intensive Care (EDIC) in 2009.

He is passionate about learning and teaching, and works with colleagues at the University of Nottingham to help develop a Centre of Excellence for non-invasive monitoring and ventilation, and sleep services.

His current research work includes neuro-respiratory failure, non-invasive ventilation (NIV), sleep medicine including sleep apnoea, and obesity and COPD.

Dr. Sovani is an active contributor of articles and case studies in all areas of transcutaneous CO2 monitoring during NIV and sleep, many of which have been referenced in clinical papers.

Who should attend?

  • Respiratory Consultants
  • Primary care physicians
  • Pulmonologists
  • Sleep physiologist
  • Respiratory Nurses

This webinar:

  1. Provide a historical review of Transcutaneous CO2 monitoring technology
  2. Illustrate how Transcutaneous CO2 monitoring works
  3. Demonstrate the use of Transcutaneous CO2 monitoring in stable patients
  4. Using Acute NIV – our study
  5. Explain the implications for Clinical Practice

Cookies are used on this website

Use of cookies
Confirm your account with Radiometer

Please enter a valid email

CONTINUE
By submitting your e-mail you agree to the data policy notice
Radiometer is using Microsoft Azure Active Directory to authenticate customer access. If you are already registered you will be taken to Microsoft AD to sign in using your Microsoft AD credentials.
You are already registered
Radiometer is using Microsoft Azure AD to authenticate customer access. If you are already registered you will be taken to AZURE to sign in using your AZURE credentials.
Thank you

We will be sending an e-mail invitation to you shortly to sign in using Microsoft Azure AD.

Radiometer is using Microsoft Azure AD to authenticate customer access.
Sorry

It seems that your e-mail is not registered with us

Radiometer is using Microsoft Azure AD to authenticate customer access. If your e-mail is not registered with us please click CONTINUE and we will guide you through the sign-in process.
We have previously sent an invitation by e-mail

Please click "Get started" in the e-mail to complete the registration process

Radiometer is using Microsoft Azure AD to authenticate customer access.
Sorry

We were not able to process your request due to a communication error

Sorry

It seems this account has not been given access to the portal

Radiometer is using Microsoft AZURE Active Directory to authenticate users

Radiometer uses Azure AD to provide our customers and partners secure access to documents, resources, and other services on our customer portal.

If your organization is already using Azure AD you can use the same credentials to access Radiometer's customer portal.

Key benefits

       
  • Allow the use of existing Active Directory credentials
  • Single-sign on experience
  • Use same credentials to access future services

Request access

You will receive an invitation to access our services via e-mail when your request has been approved.

When you accept the invitation, and your organization is already using AZURE AD, you can use the same credentials to access Radiometer's customer portal. Otherwise, a one-time password will be sent via e-mail to sign in.